Group-based CBT intervention produced modest, but sustained, reductions in measures of pain, pain-related disability
TUESDAY, Nov. 2, 2021 (HealthDay News) — For adults with chronic pain conditions receiving long-term opioid therapy, a cognitive behavioral therapy (CBT) intervention produces modest, but sustained, reductions in measures of pain and pain-related disability, according to a study published online Nov. 2 in the Annals of Internal Medicine.
Lynn DeBar, Ph.D., M.P.H., from the Kaiser Permanente Washington Health Research Institute in Seattle, and colleagues conducted a pragmatic, cluster randomized trial to examine the effectiveness of a group-based CBT intervention for chronic pain. A total of 850 adults with mixed chronic pain conditions receiving long-term opioid therapy were randomly assigned to a CBT intervention teaching pain self-management skills in 12 weekly groups versus usual care; 96 percent completed follow-up assessments.
The researchers found that on all self-reported outcomes, intervention patients sustained larger reductions from baseline to 12-month follow-up: The change in the pain intensity and interference with enjoyment of life, general activity, and sleep score was −0.434 points for pain impact, while the change was −0.060 points for pain-related disability. Intervention patients reported higher satisfaction with primary care (difference, 0.230 points) and pain services (difference, 0.336 points) at six months. The intervention group had more of a decrease in benzodiazepine use (absolute risk difference, −0.055), but there was no difference between the groups in opioid use.
“This study shows the potential for skill-based, CBT interventions delivered by frontline clinicians to reduce pain impact and improve function among patients with chronic pain receiving long-term opioid treatment,” the authors write. “Although effects were modest, they persisted after treatment through final 12-month follow-up.”
Abstract/Full Text (subscription or payment may be required)
Mivocabtagene Autoleucel Shows Promise in Stiff Person Syndrome
Lowering Doses of Maternal OUD Meds Not Linked to Severity of Neonatal Opioid Withdrawal
Rates of Drug Use-Associated Infective Endocarditis Declined From 2020 to 2022
Nonpharmacologic Therapy Cuts Opioid Use Disorder Risk With Low Back Pain
Withdrawal From Medetomidine Increasingly Seen in ICUs
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
Study Looks at Patient Experiences With Sedative Contaminating Fentanyl
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder